Background::Post-operative acute kidney injury (AKI) is one of the most common and serious complications after major surgery and is significantly associated with increased risks of morbidity and mortality. This meta-analysis was conducted to evaluate the effects of perioperative dexmedetomidine (Dex) administration on the occurrence of AKI and the outcomes of recovery after non-cardiac surgery.Methods::The PubMed, Embase, Web of Science, and Cochrane Library databases were systematically searched for studies comparing the effects of Dex vs. placebo on kidney function after non-cardiac surgery, and a pooled fixed-effect meta-analysis of the included studies was performed. The primary outcome was the occurence of post-operative AKI. The secondary outcomes included the occurence of intra-operative hypotension and bradycardia, intensive care unit (ICU) admission, duration of ICU stay, and hospital length of stay (LOS). Results::Six studies, including four randomized controlled trials (RCTs) and two observational studies, with a total of 2586 patients were selected. Compared with placebo, Dex administration could not reduce the odds of post-operative AKI (odds ratio [OR], 0.44; 95% confidence interval (CI), 0.18-1.06; P= 0.07; I2= 0.00%, P= 0.72) in RCTs, but it showed a significant renoprotective effect (OR, 0.67; 95% CI, 0.48-0.95; P = 0.02; I2 = 0.00%, P = 0.36) in observational studies. Besides, Dex administration significantly increased the odds of intra-operative bradycardia and shortened the duration of ICU stay. However, there was no significant difference in the odds of intra-operative hypotension, ICU admission, and hospital LOS. Conclusions::This meta-analysis suggests that perioperative Dex administration does not reduce the risk of AKI after non-cardiac surgery. However, the quality of evidence for this result is low due to imprecision and inconsistent types of non-cardiac operations. Thus, large and high-quality RCTs are needed to verify the real effects of perioperative Dex administration on the occurrence of AKI and the outcomes of recovery after non-cardiac surgery.

Dexmedetomidine;Non-cardiac surgery;Acute kidney injury;Meta-analysis

Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

[1]Hu Bin;Tian Tian;Li Xintao;Liu Weichao;Chen Yinggui;Jiang Tianyu;Chen Peishan;Xue Fushan-.Perioperative dexmedetomidine administration does not reduce the risk of acute kidney injury after non-cardiac surgery: a meta-analysis)[J].中华医学杂志（英文版）,2022(23):2798-2804

occurence,renoprotective

Perioperative,dexmedetomidine,administration,does,not,reduce,acute,kidney,injury,after,cardiac,surgery,meta,analysis,Background,Post,AKI,one,most,common,serious,complications,major,significantly,associated,increased,risks,morbidity,mortality,This,was,conducted,evaluate,effects,perioperative,occurrence,outcomes,recovery,Methods,Embase,Cochrane,Library,databases,were,systematically,searched,studies,comparing,placebo,function,pooled,fixed,included,performed,primary,post,secondary,intra,hypotension,bradycardia,intensive,care,unit,ICU,admission,duration,stay,hospital,length,LOS,Results,Six,including,four,randomized,controlled,trials,RCTs,two,observational,total,patients,selected,Compared,could,odds,confidence,interval,I2,but,showed,Besides,shortened,However,there,difference,Conclusions,suggests,that,quality,evidence,this,result,low,due,imprecision,inconsistent,types,operations,Thus,large,high,needed,verify,real,Dexmedetomidine,Non,Acute

0.423515